Resources

In part 4 of this Exclusive Interview, Lisa Latts talks with Diabetes in Control Publisher Steve Freed about the genesis of Watson and the work currently in the pipeline.

In part 5 of this Exclusive Interview, Lisa Latts talks with Diabetes in Control Publisher Steve Freed about the findings from the cardiovascular study for use in Watson.

In part 6 of this Exclusive Interview, Lisa Latts talks with Diabetes in Control Publisher Steve Freed about her desire to make the healthcare system work more effectively and improve the practice of medicine.

In part 7, the conclusion of this Exclusive Interview, Lisa Latts talks with Diabetes in Control Publisher Steve Freed about the Watson tools available and how to access them.

Change in albuminuria as a surrogate endpoint for progression of chronic kidney disease strongly supported by biological plausibility, but empirical evidence to support validity in epidemiological studies still lacking.

Study aims to determine whether exercise training at two distinct times of day would have differing effects on 24-hour glucose levels in men with type 2 diabetes.

Trial assesses cardiovascular benefit in patients with diabetes.

Patients with severe obesity and type 2 diabetes and without bariatric surgery are assessed to determine comparative incidence of macrovascular disease.

Which is more efficacious in improving glucose levels in individuals with type 2 diabetes -- morning, afternoon, or evening exercise? Or does it matter? Follow the link to see.

Do you tell your patients with type 2 the best time to exercise? Follow the link to see how you and your colleagues compare.